+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Peptide Therapeutics Market Research Report by Drug Class (Calcitonins, Glucagon & Analogs, Insulins, Luteinizing Hormone-Releasing Hormone, and Somatostatins), by Route of Administrator (Oral and Parental), by Technology - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4968565
  • Report
  • January 2021
  • Region: Global
  • 185 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
The Global Peptide Therapeutics Market to Grow USD 40,270.30 Million by 2025, at a CAGR of 10.96%

FEATURED COMPANIES

  • Amgen Inc
  • Bachem Holding AG
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Novartis AG
  • MORE
The Global Peptide Therapeutics Market to Grow USD 40,270.30 Million by 2025, at a CAGR of 10.96%



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Peptide Therapeutics Market is expected to grow from USD 23,940.45 Million in 2020 to USD 40,270.30 Million by the end of 2025.
2. The Global Peptide Therapeutics Market is expected to grow from EUR 20,991.44 Million in 2020 to EUR 35,309.76 Million by the end of 2025.
3. The Global Peptide Therapeutics Market is expected to grow from GBP 18,661.44 Million in 2020 to GBP 31,390.45 Million by the end of 2025.
4. The Global Peptide Therapeutics Market is expected to grow from JPY 2,555,053.34 Million in 2020 to JPY 4,297,861.54 Million by the end of 2025.
5. The Global Peptide Therapeutics Market is expected to grow from AUD 34,764.72 Million in 2020 to AUD 58,477.83 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Peptide Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Class, the Peptide Therapeutics Market is examined across Calcitonins, Glucagon & Analogs, Insulins, Luteinizing Hormone-Releasing Hormone, Somatostatins, and Vasopressin.
  • Based on Route of Administrator, the Peptide Therapeutics Market is examined across Oral and Parental.
  • Based on Technology, the Peptide Therapeutics Market is examined across Hybrid Phase, Liquid Phase, and Solid Phase.
  • Based on Geography, the Peptide Therapeutics Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Peptide Therapeutics Market including Amgen Inc, Bachem Holding AG, Eli Lilly and Co, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Novartis AG, Pfizer Inc, Sanofi, Takeda Pharmaceutical Co. Ltd, and Teva Pharmaceutical Industries Ltd.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. the ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Peptide Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Peptide Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Peptide Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Peptide Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Peptide Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Peptide Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Peptide Therapeutics Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc
  • Bachem Holding AG
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Novartis AG
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Route of Administrator Outlook
3.4. Drug Class Outlook
3.5. Technology Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Peptide Therapeutics Market, By Drug Class
6.1. Introduction
6.2. Calcitonins
6.3. Glucagon & Analogs
6.4. Insulins
6.5. Luteinizing Hormone-Releasing Hormone
6.6. Somatostatins
6.7. Vasopressin

7. Global Peptide Therapeutics Market, By Route of Administrator
7.1. Introduction
7.2. Oral
7.3. Parental

8. Global Peptide Therapeutics Market, By Technology
8.1. Introduction
8.2. Hybrid Phase
8.3. Liquid Phase
8.4. Solid Phase

9. Americas Peptide Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Peptide Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Peptide Therapeutics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Amgen Inc
13.2. Bachem Holding AG
13.3. Eli Lilly and Co
13.4. F. Hoffmann-La Roche Ltd
13.5. GlaxoSmithKline Plc
13.6. Novartis AG
13.7. Pfizer Inc
13.8. Sanofi
13.9. Takeda Pharmaceutical Co. Ltd
13.10. Teva Pharmaceutical Industries Ltd

14. Appendix
14.1. Discussion Guide

List of Figures
Figure 1. Global Peptide Therapeutics Market: Research Process
Figure 2. Global Peptide Therapeutics Market: Research Execution
Figure 3. Global Peptide Therapeutics Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Peptide Therapeutics Market Size, by Route of Administrator, 2020 (USD Million)
Figure 5. Global Peptide Therapeutics Market Size, by Drug Class, 2020 (USD Million)
Figure 6. Global Peptide Therapeutics Market Size, by Technology, 2020 (USD Million)
Figure 7. Global Peptide Therapeutics Market Size, by Geography, 2020 (USD Million)
Figure 8. Global Peptide Therapeutics Market Size, 2018-2025 (USD Million)
Figure 9. Global Peptide Therapeutics Market Size, by Geography, 2020 Vs 2025 (%)
Figure 10. Global Peptide Therapeutics Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 11. Competitive Strategic Window for Global Peptide Therapeutics Market Size, by Geography, 2025
Figure 12. Global Peptide Therapeutics Market: Market Dynamics
Figure 13. Global Peptide Therapeutics Market: Porters Five Forces Analysis
Figure 14. Global Peptide Therapeutics Market Size, by Drug Class, 2020 Vs 2025 (%)
Figure 15. Global Peptide Therapeutics Market Size, by Drug Class, 2020 Vs 2025 (USD Million)
Figure 16. Competitive Strategic Window for Global Peptide Therapeutics Market Size, by Drug Class, 2025
Figure 17. Global Peptide Therapeutics Market Size, by Calcitonins, 2020 Vs 2025 (USD Million)
Figure 18. Global Peptide Therapeutics Market Size, by Glucagon & Analogs, 2020 Vs 2025 (USD Million)
Figure 19. Global Peptide Therapeutics Market Size, by Insulins, 2020 Vs 2025 (USD Million)
Figure 20. Global Peptide Therapeutics Market Size, by Luteinizing Hormone-Releasing Hormone, 2020 Vs 2025 (USD Million)
Figure 21. Global Peptide Therapeutics Market Size, by Somatostatins, 2020 Vs 2025 (USD Million)
Figure 22. Global Peptide Therapeutics Market Size, by Vasopressin, 2020 Vs 2025 (USD Million)
Figure 23. Global Peptide Therapeutics Market Size, by Route of Administrator, 2020 Vs 2025 (%)
Figure 24. Global Peptide Therapeutics Market Size, by Route of Administrator, 2020 Vs 2025 (USD Million)
Figure 25. Competitive Strategic Window for Global Peptide Therapeutics Market Size, by Route of Administrator, 2025
Figure 26. Global Peptide Therapeutics Market Size, by Oral, 2020 Vs 2025 (USD Million)
Figure 27. Global Peptide Therapeutics Market Size, by Parental, 2020 Vs 2025 (USD Million)
Figure 28. Global Peptide Therapeutics Market Size, by Technology, 2020 Vs 2025 (%)
Figure 29. Global Peptide Therapeutics Market Size, by Technology, 2020 Vs 2025 (USD Million)
Figure 30. Competitive Strategic Window for Global Peptide Therapeutics Market Size, by Technology, 2025
Figure 31. Global Peptide Therapeutics Market Size, by Hybrid Phase, 2020 Vs 2025 (USD Million)
Figure 32. Global Peptide Therapeutics Market Size, by Liquid Phase, 2020 Vs 2025 (USD Million)
Figure 33. Global Peptide Therapeutics Market Size, by Solid Phase, 2020 Vs 2025 (USD Million)
Figure 34. Americas Peptide Therapeutics Market Size, by Geography, 2020 Vs 2025 (%)
Figure 35. Americas Peptide Therapeutics Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 36. Competitive Strategic Window for Americas Peptide Therapeutics Market Size, by Geography, 2025
Figure 37. Argentina Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 38. Brazil Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 39. Canada Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 40. Mexico Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. United States Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 42. Asia-Pacific Peptide Therapeutics Market Size, by Geography, 2020 Vs 2025 (%)
Figure 43. Asia-Pacific Peptide Therapeutics Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 44. Competitive Strategic Window for Asia-Pacific Peptide Therapeutics Market Size, by Geography, 2025
Figure 45. Australia Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 46. China Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. India Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. Indonesia Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. Japan Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. Malaysia Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. Philippines Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. South Korea Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. Thailand Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Geography, 2020 Vs 2025 (%)
Figure 55. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 56. Competitive Strategic Window for Europe, Middle East & Africa Peptide Therapeutics Market Size, by Geography, 2025
Figure 57. France Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 58. Germany Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. Italy Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Netherlands Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 61. Qatar Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 62. Russia Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. Saudi Arabia Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. South Africa Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. Spain Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. United Arab Emirates Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. United Kingdom Peptide Therapeutics Market Size, by Geography, 2018-2025 (USD Million)
Figure 68. Global Peptide Therapeutics Market: FPNV Positioning Matrix
Figure 69. Global Peptide Therapeutics Market: Market Share Analysis
Figure 70. Global Peptide Therapeutics Market: Competitor SWOT Analysis
Figure 71. Competitive Scenario Analysis in Global Peptide Therapeutics Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Peptide Therapeutics Market Size, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 3. Global Peptide Therapeutics Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 4. Global Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 5. Global Peptide Therapeutics Market Size, by Calcitonins, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 6. Global Peptide Therapeutics Market Size, by Glucagon & Analogs, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 7. Global Peptide Therapeutics Market Size, by Insulins, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 8. Global Peptide Therapeutics Market Size, by Luteinizing Hormone-Releasing Hormone, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 9. Global Peptide Therapeutics Market Size, by Somatostatins, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 10. Global Peptide Therapeutics Market Size, by Vasopressin, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 11. Global Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 12. Global Peptide Therapeutics Market Size, by Oral, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 13. Global Peptide Therapeutics Market Size, by Parental, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 14. Global Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 15. Global Peptide Therapeutics Market Size, by Hybrid Phase, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 16. Global Peptide Therapeutics Market Size, by Liquid Phase, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 17. Global Peptide Therapeutics Market Size, by Solid Phase, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 18. Americas Peptide Therapeutics Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 19. Americas Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 20. Americas Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 21. Americas Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 22. Argentina Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 23. Argentina Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 24. Argentina Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 25. Brazil Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 26. Brazil Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 27. Brazil Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 28. Canada Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 29. Canada Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 30. Canada Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 31. Mexico Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 32. Mexico Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 33. Mexico Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 34. United States Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 35. United States Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 36. United States Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 37. Asia-Pacific Peptide Therapeutics Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 38. Asia-Pacific Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 39. Asia-Pacific Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 40. Asia-Pacific Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 41. Australia Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 42. Australia Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 43. Australia Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 44. China Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 45. China Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 46. China Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 47. India Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 48. India Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 49. India Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 50. Indonesia Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 51. Indonesia Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 52. Indonesia Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 53. Japan Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 54. Japan Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 55. Japan Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 56. Malaysia Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 57. Malaysia Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 58. Malaysia Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 59. Philippines Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 60. Philippines Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 61. Philippines Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 62. South Korea Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 63. South Korea Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 64. South Korea Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 65. Thailand Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 66. Thailand Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 67. Thailand Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 68. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 69. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 70. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 71. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 72. France Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 73. France Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 74. France Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 75. Germany Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 76. Germany Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 77. Germany Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 78. Italy Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 79. Italy Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 80. Italy Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 81. Netherlands Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 82. Netherlands Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 83. Netherlands Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 84. Qatar Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 85. Qatar Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 86. Qatar Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 87. Russia Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 88. Russia Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 89. Russia Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 90. Saudi Arabia Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 91. Saudi Arabia Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 92. Saudi Arabia Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 93. South Africa Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 94. South Africa Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 95. South Africa Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 96. Spain Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 97. Spain Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 98. Spain Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 99. United Arab Emirates Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 100. United Arab Emirates Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 101. United Arab Emirates Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 102. United Kingdom Peptide Therapeutics Market Size, by Route of Administrator, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 103. United Kingdom Peptide Therapeutics Market Size, by Drug Class, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 104. United Kingdom Peptide Therapeutics Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 105. Global Peptide Therapeutics Market: Scores
Table 106. Global Peptide Therapeutics Market: Business Strategy
Table 107. Global Peptide Therapeutics Market: Product Satisfaction
Table 108. Global Peptide Therapeutics Market: Ranking
Table 109. Global Peptide Therapeutics Market: Merger & Acquisition
Table 110. Global Peptide Therapeutics Market: Agreement, Collaboration, & Partnership
Table 111. Global Peptide Therapeutics Market: New Product Launch & Enhancement
Table 112. Global Peptide Therapeutics Market: Investment & Funding
Table 113. Global Peptide Therapeutics Market: Award, Recognition, & Expansion
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Amgen Inc
  • Bachem Holding AG
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll